CKD patients: the dilemma of serum PTH levels
- PMID: 20639672
- DOI: 10.1159/000318787
CKD patients: the dilemma of serum PTH levels
Abstract
Recent observational studies of patients with stage 3-5 chronic kidney disease (CKD) not undergoing dialysis have shown that even slight increases in parathyroid hormone (PTH) levels are associated with an increased cardiovascular risk, regardless of the serum levels of calcium and phosphorus and vitamin D therapy. These studies suggest paying particular attention to monitoring PTH levels from the early stages of CKD, and preventing any mineral metabolism disorders that may trigger the excessive synthesis and secretion of PTH. However, it is not easy to determine when an appropriate response becomes maladaptive and requires the pharmacological suppression of the parathyroid gland because the gland's adaptive response can vary widely from one person to another. Furthermore, PTH levels are not always a good predictor of bone turnover and current PTH assays have various methodological limitations. Treating the early mineral metabolism abnormalities of CKD may help prevent the cardiovascular complications whose frequency, costs and mortality have a profound effect on society as a whole. For this reason, there is great interest in establishing adequate target ranges for PTH at different stages of CKD, and determining the most appropriate strategies for reaching them.
Copyright © 2010 S. Karger AG, Basel.
Similar articles
-
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.Am J Nephrol. 2007;27(1):36-43. doi: 10.1159/000098561. Epub 2007 Jan 11. Am J Nephrol. 2007. PMID: 17215573 Clinical Trial.
-
Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD.Nephron Clin Pract. 2011;118(2):c78-85. doi: 10.1159/000320318. Epub 2010 Dec 8. Nephron Clin Pract. 2011. PMID: 21150215
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029. Am J Kidney Dis. 2009. PMID: 19285609
-
Mineral metabolism disturbances in patients with chronic kidney disease.Eur J Clin Invest. 2007 Aug;37(8):607-22. doi: 10.1111/j.1365-2362.2007.01840.x. Eur J Clin Invest. 2007. PMID: 17635571 Review.
Cited by
-
Assessment of regional and total skeletal metabolism using 18F-NaF PET/CT in patients with chronic kidney disease.Ann Nucl Med. 2024 Jul;38(7):563-573. doi: 10.1007/s12149-024-01929-1. Epub 2024 Apr 27. Ann Nucl Med. 2024. PMID: 38676905
-
Cardiac transcriptomic changes induced by early CKD in mice reveal novel pathways involved in the pathogenesis of Cardiorenal syndrome type 4.Heliyon. 2024 Mar 8;10(6):e27468. doi: 10.1016/j.heliyon.2024.e27468. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38509984 Free PMC article.
-
Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study.J Am Heart Assoc. 2023 Jul 18;12(14):e028561. doi: 10.1161/JAHA.122.028561. Epub 2023 Jul 8. J Am Heart Assoc. 2023. PMID: 37421259 Free PMC article.
-
The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus.Int J Mol Sci. 2022 Sep 23;23(19):11196. doi: 10.3390/ijms231911196. Int J Mol Sci. 2022. PMID: 36232497 Free PMC article.
-
Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease.Med Sci Monit. 2018 Jul 10;24:4760-4766. doi: 10.12659/MSM.909259. Med Sci Monit. 2018. PMID: 29987270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical